Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03330080 · ClinicalTrials.gov registry record
Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients
A clinical trial of Craniopharyngioma, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 41
- Enrollment target
- 1
- Study location
NCT03330080: Completed study of Craniopharyngioma, sponsored by St. Jude Children's Research Hospital.
NCT03330080 is a study of Craniopharyngioma that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 41 participants, below the 209-participant average among 6 other Craniopharyngioma trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03330080, a study of Craniopharyngioma, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
Pediatric craniopharyngioma patients experience significant endocrine and sleep dysregulation difficulties. Sleep is a crucial part of children's healthy development, and sleep difficulties are associated with severe functional morbidity. Insufficient sleep, excessive daytime sleepiness, and poor sleep quality have all been significantly related to academic, behavioral, and emotional functioning in children and adolescents. Ecological momentary assessments (EMA) will be used to collect observational data. EMA data will be collected twice daily for one week. For the morning EMA administration, participants will be asked about their sleep. During the evening administration, participants will be asked about their daytime sleepiness, overall well-being, and family functioning. Covariates also administered during the evening administration include medication administration (Y/N) and total screen time. At the end of the EMA data collection period (on day 7 OR 8), participants will be sent a survey asking them to report - anonymously - their overall experience and satisfaction with the EMA data collection method.
Primary Outcome
Study feasibility will be assessed by calculating the participation rate as follows: the number of participants who agree to participants divided by the number who are approached to participate.
Conditions Studied
Study Locations (1)
Tennessee
- St . Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2019-01-29 |
What the finished NCT03330080 record still lists
NCT03330080 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 209-participant average among 6 other Craniopharyngioma trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Craniopharyngioma appearing as the primary indexed condition, and to 0 interventions.
NCT03330080 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03330080 about?
NCT03330080 is a clinical study titled "Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients". Pediatric craniopharyngioma patients experience significant endocrine and sleep dysregulation difficulties. Sleep is a crucial part of children's healthy development, and sleep difficulties are associated with severe functional morbidity. Insufficient sleep, excessive daytime sleepiness, and poor sl...
What is the current status of trial NCT03330080?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2018-02-12. Estimated completion is 2019-01-29.
What conditions does trial NCT03330080 study?
This clinical trial studies the following conditions: Craniopharyngioma.
Who is sponsoring clinical trial NCT03330080?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03330080 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Craniopharyngioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
RECRUITING · Phase 2
-
Long-Term Longitudinal QoL in Patients Undergoing EEA
RECRUITING
-
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
RECRUITING · Phase 2
-
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
ACTIVE NOT RECRUITING · Phase 2
-
Methionine PET/CT Studies In Patients With Cancer
ACTIVE NOT RECRUITING · Phase 2
-
A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI